Extracellular Vesicles in Alcoholic Liver Injury

  • Akiko Eguchi
  • Yoshiyuki TakeiEmail author


Alcoholic liver disease (ALD) is one of the most common forms of chronic liver disease in the world; it is a major cause of chronic illness and mortality associated with alcohol over-consumption. ALD represents a broad spectrum of liver injury, such as hepatocyte cell death, liver inflammation, angiogenesis, and fibrosis leading to cirrhosis and hepatocellular carcinoma. Chronic ethanol consumption results in hepatic lipid accumulation and increases cell stress, which leads to inflammation and liver injury during the progression of ALD. It has been shown that crosstalk between hepatocytes and non-parenchymal cells is significantly important. The identifying factors that communicate stress signals from hepatocytes, and may initiate and perpetuate the inflammatory reaction responsible for liver injury and disease progression from steatohepatitis to cirrhosis may have a tremendous biomedical impact. Furthermore, the elucidation of these molecular mechanisms of crosstalk may allow for the identification of an individualized therapeutic approach in the treatment of patients with different stages of ALD and for the development of biomarkers to diagnose ALD progression. Recently, extracellular vesicles (EVs) have been identified as cell-to-cell communicators, the cellular contents of which contain proteins, lipids, and RNAs from stressed/activated cells and transfer this cellular payload to target cells. In this chapter, we will focus on current reports of EV function, how they are involved in the molecular pathogenesis of ALD, and EV biomarkers using EV composition.


Extracellular vesicles Alcoholic liver injury ALD ASH AH 



This work was partially supported by JSPS KAKENHI Grant Number JP16H06872 to AE and JSPS KAKENHI Grant Number JP17K09419 to YT.

Conflicts of Interest

No potential conflict of interest relevant to this article was reported.


  1. 1.
    Rehm J, Samokhvalov AV, Shield KD. Global burden of alcoholic liver diseases. J Hepatol. 2013;59:160–8. Scholar
  2. 2.
    Stickel F, Datz C, Hampe J, Bataller R. Pathophysiology and management of alcoholic liver disease: update 2016. Gut Liver. 2017;11:173–88. Scholar
  3. 3.
    Bocca C, Novo E, Miglietta A, Parola M. Angiogenesis and fibrogenesis in chronic liver diseases. Cell Mol Gastroenterol Hepatol. 2015;1:477–88. Scholar
  4. 4.
    Hirsova P, Ibrahim SH, Verma VK, Morton LA, Shah VH, LaRusso NF, Gores GJ, Malhi H. Extracellular vesicles in liver pathobiology: small particles with big impact. Hepatology. 2016;64:2219–33. Scholar
  5. 5.
    Povero D, Feldstein AE. Novel molecular mechanisms in the development of non-alcoholic steatohepatitis. Diabetes Metab J. 2016;40:1–11. Scholar
  6. 6.
    Szabo G, Momen-Heravi F. Extracellular vesicles in liver disease and potential as biomarkers and therapeutic targets. Nat Rev Gastroenterol Hepatol. 2017;14:455–66. Scholar
  7. 7.
    Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013;200:373–83. Scholar
  8. 8.
    Yanez-Mo M, Siljander PR, Andreu Z, Zavec AB, Borras FE, Buzas EI, Buzas K, Casal E, Cappello F, Carvalho J, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015;4:27066. Scholar
  9. 9.
    Maas SLN, Breakefield XO, Weaver AM. Extracellular vesicles: unique intercellular delivery vehicles. Trends Cell Biol. 2017;27:172–88. Scholar
  10. 10.
    Chen K, Rajewsky N. The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet. 2007;8:93–103. Scholar
  11. 11.
    Eguchi A, Lazaro RG, Wang J, Kim J, Povero D, Willliams B, Ho SB, Starkel P, Schnabl B, Ohno-Machado L, et al. Extracellular vesicles released by hepatocytes from gastric infusion model of alcoholic liver disease contain a MicroRNA barcode that can be detected in blood. Hepatology. 2017;65:475–90. Scholar
  12. 12.
    Verma VK, Li H, Wang R, Hirsova P, Mushref M, Liu Y, Cao S, Contreras PC, Malhi H, Kamath PS, et al. Alcohol stimulates macrophage activation through caspase-dependent hepatocyte derived release of CD40L containing extracellular vesicles. J Hepatol. 2016;64:651–60. Scholar
  13. 13.
    Eguchi A, Kim J, Ohno-Machado L, Tsukamoto H, Feldstein AE. Hepatocytes from mice on intragastric feeding model of alcoholic steatohepatitis release extracellular vesicles with specific microRNA cargo that modulate hepatic stellate cell and macrophage phenotype. Hepatology. 2015;62:266A–7A.Google Scholar
  14. 14.
    Cai Y, Xu MJ, Koritzinsky EH, Zhou Z, Wang W, Cao H, Yuen PS, Ross RA, Star RA, Liangpunsakul S, et al. Mitochondrial DNA-enriched microparticles promote acute-on-chronic alcoholic neutrophilia and hepatotoxicity. JCI Insight. 2017;2:92634. Scholar
  15. 15.
    Saha B, Momen-Heravi F, Furi I, Kodys K, Catalano D, Gangopadhyay A, Haraszti R, Satishchandran A, Iracheta-Vellve A, Adejumo A, et al. Extracellular vesicles from mice with alcoholic liver disease carry a distinct protein cargo and induce macrophage activation via Hsp90. Hepatology. 2017;67(5):1986–2000. Scholar
  16. 16.
    Ambade A, Catalano D, Lim A, Kopoyan A, Shaffer SA, Mandrekar P. Inhibition of heat shock protein 90 alleviates steatosis and macrophage activation in murine alcoholic liver injury. J Hepatol. 2014;61:903–11. Scholar
  17. 17.
    Saha B, Momen-Heravi F, Kodys K, Szabo G. MicroRNA cargo of extracellular vesicles from alcohol-exposed monocytes signals naive monocytes to differentiate into M2 macrophages. J Biol Chem. 2016;291:149–59. Scholar
  18. 18.
    Eguchi A, Wree A, Feldstein AE. Biomarkers of liver cell death. J Hepatol. 2014;60:1063–74. Scholar
  19. 19.
    Momen-Heravi F, Saha B, Kodys K, Catalano D, Satishchandran A, Szabo G. Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis. J Transl Med. 2015;13:261. Scholar
  20. 20.
    Povero D, Eguchi A, Li H, Johnson CD, Papouchado BG, Wree A, Messer K, Feldstein AE. Circulating extracellular vesicles with specific proteome and liver microRNAs are potential biomarkers for liver injury in experimental fatty liver disease. PLoS One. 2014;9:e113651. Scholar
  21. 21.
    Garcia-Martinez I, Santoro N, Chen Y, Hoque R, Ouyang X, Caprio S, Shlomchik MJ, Coffman RL, Candia A, Mehal WZ. Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9. J Clin Invest. 2016;126:859–64. Scholar
  22. 22.
    Povero D, Eguchi A, Niesman IR, Andronikou N, de Mollerat du Jeu X, Mulya A, Berk M, Lazic M, Thapaliya S, Parola M, et al. Lipid-induced toxicity stimulates hepatocytes to release angiogenic microparticles that require Vanin-1 for uptake by endothelial cells. Sci Signal. 2013;6:ra88. Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  1. 1.Department of Gastroenterology and HepatologyGraduate School of Medicine, Mie UniversityTsuJapan

Personalised recommendations